Clinical Grade Non-Transfusable Mobilized Peripheral Blood CD62L+ Cells, G-CSF + Plerixafor, Frozen
CD62L, also known as L-selectin, is expressed on a wide range of peripheral blood cells including B cells, T cells, monocytes, and granulocytes, to name a few.
Human mobilized peripheral blood CD62L+ cells are isolated from the mononuclear cell fraction by means of positive selection. Cells expressing CD62L are enriched from the mononuclear cell population using CD62L immunomagnetic beads. CD62L+ cells are characterized by flow cytometry before cryopreservation to ensure a highly pure and viable cell population.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols. All reagents and devices used in the collection and separation process are certified clinical grade. This item is for research use only.
|Cell and Tissue Source||Peripheral Blood|
|Product Type||Primary Cells|
|Cell Type||T Cells|
|Donor Attributes||HIV-, HepB-, HepC-|
|Purity||≥85% by Flow Cytometry|
|Viability||≥70% by Flow Cytometry|
|Contains||CryoStor™ CS10 (10% DMSO)|
|Injections||10μg/kg/day of G-CSF & 240μg/kg Plerixafor the day before collection|